Berlin: Bayer has announced the submission of a marketing authorization application to the European Medicines Agency (EMA) ...

Data obtained by CTV News from Health Canada shows that 85 per cent of inspections of drug manufacturing sites supplying the ...

Full data from Phase 3 TRANSCEND study underscore potential efficacy of setmelanotide, including with prior use or concomitant use of GLP-1s - BOSTON, July 12, 2025 (GLOBE NEWSWIRE) -- Rhythm ...

By Dr. Thandiwe Mwale, Governance and Anti-Corruption Specialist Introduction: A Diplomatic Death Certificate Rune Skinnebach ...